Taams Lab

Just search for Taamslab in a bright blue 🦋sky

Dear followers, we have moved our account to 🦋 Please come and follow us again there. Looking forward to re-connecting!!

Congratulations to @denk_lab - a well deserved recognition!

Following the retirement of Professor Anthony Dorling, @KingsCollegeLon and @GSTTnhs are looking for an exceptional academic leader to shape transplant immunology & nephrology research at King’s and help reinvigorate the field in the UK

This work forms part of a wonderful collaborative effort between neuroscientists, pain biologists, rheumatologists and immunologists @denk_lab @arthritisbham @ZoeRutter2 @bannister_lab and others, funded by @NIHRresearch and @wellcometrust #pain #arthritis #TeamScience

Delighted to share our latest review article in which we describe our interdisciplinary perspective towards better understanding of and research into the peripheral drivers of pain in rheumatoid arthritis rdcu.be/dTa4l

Interested in joint inflammation & inflammatory arthritis? Then have a look at our recent paper doi.org/10.1002/art.42… in which we show substantive similarities in the phenotype and TCR repertoires of synovial fluid and synovial tissue derived T cells!

We are pleased to announce the establishment of the Roger Williams Institute of Liver Studies, bringing together @f4liverresearch's Roger Williams @Inst_of_Hep and @KCLImmunoMicro Institute of Liver Studies under the leadership of Prof Philip Newsome ⬇️ kcl.ac.uk/news/kings-col…

The Institute represents an exciting opportunity to combine resources and research strengths across @KingsCollegeLon, @KingsCollegeNHS and the @Inst_of_Hep, enabling the delivery of the very highest quality liver research at scale. @phil_newsome7 @kingshealth @Taams_Lab

So happy to share this great output from a wonderful and long-standing neuro-immune collaboration with @denk_lab funded by @wellcometrust

Big congratulations and thanks to the team @giopovo @M_L_Ridley et al. for your hard work and perseverance and thank you to @discovimmunol for publishing the work!

This paper follows from our previous work which showed an increase in IL-10 expressing CD4+ T cells following anti-TNF therapy in vitro and in vivo. We used RNASeq and ATACseq to identify a putative transcriptional network consisting of MAF, PRDM1 and/or EOMES that may drive this

Very happy to share our latest paper funded by our @VersusArthritis programme grant: Identification of a transcription factor network regulating anti-TNF mediated IL10 expression in human CD4+ T cells academic.oup.com/discovimmunolo…

And here is the link to our other paper on pain in inflammatory arthritis - a wonderful collaboration with @ZoeRutter2, @bannister_lab, Bruce Kirkham and Heidi Lempp and most importantly, with individuals living with painful #arthritis: onlinelibrary.wiley.com/doi/10.1111/he…

One of two recent publications authored by our wonderful clinical fellow @ZoeRutter2 in collaboration with @bannister_lab and @denk_lab and others - working together towards a better understanding and treatment of pain in inflammatory #arthritis

Vacancy alert 📢 Could you be our next Editor-in-Chief? We are looking for someone who can provide visionary leadership, foster a culture of excellence and plan for the journal’s growth. Deadline: Monday 8 July. Find out more and apply 👉 immunology.org/news/vacancy-e…

Another major milestone for our #OpenAccess journal @discovimmunol, part of the BSI journals family with @CEIjournal & @IMTadvances! And another reason to contribute with your work…on top of: 🔸Fast turnaround 🔸Dedicated promotion 🔸Supporting our grants, events & careers work

Congratulations to @Taams_Lab's Lucy, just passed her PhD viva 🥳🥂

If you're interested in #neuroimmunology, check out @BSI_neuroimmune's #Neuroimmuno24 event! It will welcome 13 fantastic speakers covering diverse areas of #neuroimmune #research💡 Submit your abstract by Monday 18 March to take part 👉bit.ly/48BNm17

Check out this important study by Prof Andrew Cope and team @KCL_CIBCI @KCLImmunoMicro on prevention of RA in people at high risk of the disease